New diabetes clinical trial: Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes Mellitus Diagnosed at 24-28 Weeks' Gestation

Published on: November 09, 2023 at 11:00PM
Conditions: Gestational Diabetes
Interventions: Drug: 500 mg of ursodeoxycholic acid (UDCA); Other: 500 mg of Placebo
Sponsors: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Completed
https://ift.tt/wjFvJeI